• LAST PRICE
    2.0000
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    2.0000/ 51
  • Ask / Lots
    2.0800/ 1
  • Open / Previous Close
    2.0000 / 2.0000
  • Day Range
    Low 2.0000
    High 2.0100
  • 52 Week Range
    Low 1.6200
    High 4.2700
  • Volume
    4,540
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 2
TimeVolumeTKNO
09:38 ET3892
09:39 ET2002
09:41 ET7002
09:43 ET5742
09:45 ET3002
09:48 ET2002
09:50 ET3002
09:52 ET3002
09:54 ET3002
09:56 ET2002
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesTKNO
Alpha Teknova Inc
81.6M
-1.7x
---
United StatesKRMD
KORU Medical Systems Inc
97.4M
-7.3x
---
United StatesPDEX
Pro-Dex Inc
65.1M
13.7x
+37.17%
United StatesMYO
Myomo Inc
98.0M
-13.0x
---
United StatesAPT
Alpha Pro Tech Ltd
68.2M
16.9x
+6.36%
United StatesASXC
Asensus Surgical Inc
68.0M
-0.8x
---
As of 2024-04-23

Company Information

Alpha Teknova, Inc. is a producer of critical reagents for the research, discovery, development, and commercialization of therapies, vaccines, and molecular diagnostics. It offers two primary business lines, which include lab essentials and clinical solutions. It also offers three primary product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. The Company offers its liquid cell culture media and supplements and molecular biology reagents in both of its two product categories; pre-poured media plates are available in its Lab Essentials category only. Its customers include pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostics franchises, and academic and government research institutions developing vaccines and therapies and performing basic research.

Contact Information

Headquarters
2451 Bert DriveHOLLISTER, CA, United States 95023
Phone
831-637-1100
Fax
845-818-3588

Executives

Non-Executive Chairman of the Board
Paul Grossman
President, Chief Executive Officer, Director
Stephen Gunstream
Chief Financial Officer
Matthew Lowell
Chief Compliance Officer, General Counsel
Damon Terrill
Director
Irene Davis

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$81.6M
Revenue (TTM)
$36.7M
Shares Outstanding
40.8M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-1.17
Book Value
$2.21
P/E Ratio
-1.7x
Price/Sales (TTM)
2.2
Price/Cash Flow (TTM)
---
Operating Margin
-99.19%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.